Durvalumab Pre, Post Surgery in NSCLC: Is Practice Changing?

Published Date: 22 Apr 2023

Neoadjuvant immunotherapy for patients with resectable non-small cell lung cancer has been shown to be beneficial in two phase 3 studies, including the AEGEAN trial and Checkmate 816.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

3.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

4.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

5.

A promising medication could slow brain tumors in children.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot